{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:13:15Z","timestamp":1790773995262,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00296-017-3843-x","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T08:50:46Z","timestamp":1508230246000},"page":"2105-2114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Tatjana","family":"Zeki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana Stani\u0107","family":"Beni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Antulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Anton\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sr\u0111an","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","volume":"259","author":"TG Liman","year":"2012","unstructured":"Liman TG, Bohner G, Heuschmann PU et al (2012) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 259:155\u2013164. doi:\n                        10.1007\/s00415-011-6152-4","journal-title":"J Neurol"},{"key":"3843_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/NRL.0000000000000105","volume":"21","author":"J How","year":"2016","unstructured":"How J, Blattner M, Fowler S et al (2016) Chemotherapy-associated posterior reversible encephalopathy syndrome: a case report and review of the literature. Neurologist 21:112\u2013117. doi:\n                        10.1097\/NRL.0000000000000105","journal-title":"Neurologist"},{"key":"3843_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clineuro.2008.11.017","volume":"111","author":"JF Baizabal-Carvallo","year":"2009","unstructured":"Baizabal-Carvallo JF, Barragan-Campos HM, Padilla-Aranda HJ et al (2009) Posterior reversible encephalopathy syndrome as a complication of acute lupus activity. Clin Neurol Neurosurg 111:359\u2013363. doi:\n                        10.1016\/j.clineuro.2008.11.017","journal-title":"Clin Neurol Neurosurg"},{"key":"3843_CR4","unstructured":"European Medicine Agency European database of suspected adverse drug reaction reports. \n                        https:\/\/bi.ema.europa.eu\/analyticsSOAP\/saw.dll?PortalPages&PortalPath=%2Fshared%2FDAP%2F_portal%2FDAP&Action=Navigate&P0=1&P1=eq&P2=%22Line\n                        \n                     Listing Objects%22.%22Substance High Level Code%22&P3\u00a0=\u00a01+18356. Accessed 14 Mar 2017"},{"key":"3843_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/0961203313496341","volume":"22","author":"SM Jung","year":"2013","unstructured":"Jung SM, Moon S-J, Kwok S-K et al (2013) Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus 22:885\u2013891. doi:\n                        10.1177\/0961203313496341","journal-title":"Lupus"},{"key":"3843_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245. doi:\n                        10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"3843_CR7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D et al (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121\u20132131. doi:\n                        10.1002\/art.10461","journal-title":"Arthritis Rheum"},{"key":"3843_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/0961203307078682","volume":"16","author":"ML Ishimori","year":"2007","unstructured":"Ishimori ML, Pressman BD, Wallace DJ, Weisman MH (2007) Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus 16:436\u2013443. doi:\n                        10.1177\/0961203307078682","journal-title":"Lupus"},{"key":"3843_CR9","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3899\/jrheum.101308","volume":"38","author":"IR Varaprasad","year":"2011","unstructured":"Varaprasad IR, Agrawal S, Prabu VNN et al (2011) Posterior reversible encephalopathy syndrome in systemic Lupus erythematosus. J Rheumatol 38:1607\u20131611. doi:\n                        10.3899\/jrheum.101308","journal-title":"J Rheumatol"},{"key":"3843_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0961203307085405","volume":"17","author":"G Leroux","year":"2008","unstructured":"Leroux G, Sellam J, Costedoat-Chalumeau N et al (2008) Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 17:139\u2013147. doi:\n                        10.1177\/0961203307085405","journal-title":"Lupus"},{"key":"3843_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","volume":"44","author":"ME Jonge de","year":"2005","unstructured":"de Jonge ME, Huitema ADR, Rodenhuis S, Beijnen JH (2005) Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 44:1135\u20131164. doi:\n                        10.2165\/00003088-200544110-00003","journal-title":"Clin Pharmacokinet"},{"key":"3843_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3747\/pdi.2012.00152","volume":"32","author":"EV Hobson","year":"2012","unstructured":"Hobson EV, Craven I, Blank SC (2012) Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int 32:590\u2013594. doi:\n                        10.3747\/pdi.2012.00152","journal-title":"Perit Dial Int"},{"key":"3843_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/0885066610393634","volume":"27","author":"D Staykov","year":"2012","unstructured":"Staykov D, Schwab S (2012) Posterior reversible encephalopathy syndrome. J Intensive Care Med 27:11\u201324. doi:\n                        10.1177\/0885066610393634","journal-title":"J Intensive Care Med"},{"key":"3843_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0031-1277990","volume":"31","author":"SK Feske","year":"2011","unstructured":"Feske SK (2011) Posterior reversible encephalopathy syndrome: a review. Semin Neurol 31:202\u2013215. doi:\n                        10.1055\/s-0031-1277990","journal-title":"Semin Neurol"},{"key":"3843_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4078\/jrd.2013.20.2.103","volume":"20","author":"CH Lee","year":"2013","unstructured":"Lee CH, Lee YM, Ahn SH, Ryu DW, Song JH, Lee MS (2013) Cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with lupus nephritis. J Rheum Dis 20:103\u2013107","journal-title":"J Rheum Dis"},{"key":"3843_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4065\/77.6.557","volume":"77","author":"GK Dy","year":"2002","unstructured":"Dy GK, Swaroop VS (2002) 31-year-old woman with confusion and labile behavior. Mayo Clin Proc 77:557\u2013560. doi:\n                        10.4065\/77.6.557","journal-title":"Mayo Clin Proc"},{"key":"3843_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semarthrit.2006.01.002","volume":"35","author":"MD Magnano","year":"2006","unstructured":"Magnano MD, Bush TM, Herrera I, Altman RD (2006) Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 35:396\u2013402. doi:\n                        10.1016\/j.semarthrit.2006.01.002","journal-title":"Semin Arthritis Rheum"},{"key":"3843_CR18","first-page":"2430, 2434, 249","volume":"72","author":"DV Pasupuleti","year":"2005","unstructured":"Pasupuleti DV, Miranda M, Vattipally V (2005) Case report: posterior reversible encephalopathy syndrome. Am Fam Physician 72:2430, 2434, 2496","journal-title":"Am Fam Physician"},{"key":"3843_CR19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.60.5.534","volume":"60","author":"A Primavera","year":"2001","unstructured":"Primavera A, Audenino D, Mavilio N, Cocito L (2001) Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 60:534\u2013537","journal-title":"Ann Rheum Dis"},{"key":"3843_CR20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.hjh.0000084751.37215.d2","volume":"21","author":"JA Whitworth","year":"2003","unstructured":"Whitworth JA (2003) 2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983\u20131992. doi:\n                        10.1097\/01.hjh.0000084751.37215.d2","journal-title":"J Hypertens"},{"key":"3843_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2377-12-152","volume":"12","author":"B Liu","year":"2012","unstructured":"Liu B, Zhang X, Zhang F-C et al (2012) Posterior reversible encephalopathy syndrome could be an underestimated variant of \u201creversible neurological deficits\u201d in systemic lupus erythematosus. BMC Neurol 12:152. doi:\n                        10.1186\/1471-2377-12-152","journal-title":"BMC Neurol"},{"key":"3843_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00127893-200201000-00003","volume":"8","author":"RB Schwartz","year":"2002","unstructured":"Schwartz RB (2002) Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist 8:22\u201334","journal-title":"Neurologist"},{"key":"3843_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002265.pub3","author":"V Fernandes Moca Trevisani","year":"2013","unstructured":"Fernandes Moca Trevisani V, Castro AA, Neves Neto JF, Atallah AN (2013) Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane database Syst Rev. doi:\n                        10.1002\/14651858.CD002265.pub3","journal-title":"Cochrane database Syst Rev"},{"key":"3843_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10165-010-0386-3","volume":"21","author":"Y Fujieda","year":"2011","unstructured":"Fujieda Y, Kataoka H, Odani T et al (2011) Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus. Mod Rheumatol 21:276\u2013281. doi:\n                        10.1007\/s10165-010-0386-3","journal-title":"Mod Rheumatol"},{"key":"3843_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. doi:\n                        10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"3843_CR26","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/rheumatology\/keh305","volume":"43","author":"CP Mavragani","year":"2004","unstructured":"Mavragani CP, Vlachoyiannopoulos PG, Kosmas N et al (2004) A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford) 43:1450\u20131451. doi:\n                        10.1093\/rheumatology\/keh305","journal-title":"Rheumatology (Oxford)"},{"key":"3843_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4065\/mcp.2009.0590","volume":"85","author":"JE Fugate","year":"2010","unstructured":"Fugate JE, Claassen DO, Cloft HJ et al (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427\u2013432. doi:\n                        10.4065\/mcp.2009.0590","journal-title":"Mayo Clin Proc"},{"key":"3843_CR28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-7753(05)72167-9","volume":"125","author":"L Caminal-Montero","year":"2005","unstructured":"Caminal-Montero L, Trapiella-Martinez L, Suarez-Casado H, Garcia-Garcia J (2005) Reversible posterior leucoencephalopathy in systemic lupus. Med Clin (Barc) 125:719","journal-title":"Med Clin (Barc)"},{"key":"3843_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ejrad.2006.12.001","volume":"62","author":"R Gocmen","year":"2007","unstructured":"Gocmen R, Ozgen B, Oguz KK (2007) Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol 62:454\u2013459. doi:\n                        10.1016\/j.ejrad.2006.12.001","journal-title":"Eur J Radiol"},{"key":"3843_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/RHU.0b013e318262249b","volume":"18","author":"HK Grewal","year":"2012","unstructured":"Grewal HK, Saketkoo LA, Garcia-Valladares I, Espinoza LR (2012) Central nervous system involvement including visual loss in a patient with systemic lupus erythematosus with posterior reversible leukoencephalopathy syndrome. J Clin Rheumatol 18:263\u2013264. doi:\n                        10.1097\/RHU.0b013e318262249b","journal-title":"J Clin Rheumatol"},{"key":"3843_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00296-014-3173-1","volume":"35","author":"M Jabrane","year":"2015","unstructured":"Jabrane M, Lahcen ZA, Fadili W, Laouad I (2015) A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide. Rheumatol Int 35:935\u2013938. doi:\n                        10.1007\/s00296-014-3173-1","journal-title":"Rheumatol Int"},{"key":"3843_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/1752-1947-8-442","volume":"8","author":"JL Jayaweera","year":"2014","unstructured":"Jayaweera JL, Withana MR, Dalpatadu CKP et al (2014) Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report. J Med Case Rep 8:442. doi:\n                        10.1186\/1752-1947-8-442","journal-title":"J Med Case Rep"},{"key":"3843_CR33","first-page":"572","volume":"23","author":"H Kadikoy","year":"2012","unstructured":"Kadikoy H, Haque W, Hoang V et al (2012) Posterior reversible encephalopathy syndrome in a patient with lupus nephritis. Saudi J Kidney Dis Transpl 23:572\u2013576","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3843_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.semarthrit.2006.01.003","volume":"35","author":"LL Min","year":"2006","unstructured":"Min LL, Zwerling J, Ocava LC et al (2006) Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 35:388\u2013395. doi:\n                        10.1016\/j.semarthrit.2006.01.003","journal-title":"Semin Arthritis Rheum"},{"key":"3843_CR35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00247-009-1540-y","volume":"40","author":"E Muscal","year":"2010","unstructured":"Muscal E, Traipe E, de Guzman MM et al (2010) MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus. Pediatr Radiol 40:1241\u20131245. doi:\n                        10.1007\/s00247-009-1540-y","journal-title":"Pediatr Radiol"},{"key":"3843_CR36","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/08830738050200121201","volume":"20","author":"H Ozyurek","year":"2005","unstructured":"Ozyurek H, Oguz G, Ozen S et al (2005) Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol 20:990\u2013993. doi:\n                        10.1177\/08830738050200121201","journal-title":"J Child Neurol"},{"key":"3843_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0887-8994(96)00292-5","volume":"16","author":"SG Pavlakis","year":"1997","unstructured":"Pavlakis SG, Frank Y, Kalina P et al (1997) Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol 16:145\u2013148","journal-title":"Pediatr Neurol"},{"key":"3843_CR38","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/ndt\/gfg347","volume":"18","author":"PFK Yong","year":"2003","unstructured":"Yong PFK, Hamour SMA, Burns A (2003) Reversible posterior leukoencephalopathy in a patient with systemic sclerosis\/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 18:2660\u20132662","journal-title":"Nephrol Dial Transplant"},{"key":"3843_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3843-x","author":"T Zeki\u0107","year":"2017","unstructured":"Zeki\u0107 T, Stani\u0107 Beni\u0107 M, Antulov R, Anton\u010di\u0107 I, Novak S (2017) The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients. Rheumatol Int. doi:\n                        10.1007\/s00296-017-3843-x","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3843-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3843-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3843-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T12:35:55Z","timestamp":1509971755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3843-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3843-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]}}}